Senior insider sale
SUPERNUS PHARMACEUTICALS, INC. — senior position signals high conviction
$537.1K
10K shares
What this filing means
GEMAYEL GEORGES plans to sell 10K shares of SUPERNUS PHARMACEUTICALS, INC. valued at approximately $537.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/5/2026ACC: 0001950047-26-002236
Director
Since Feb 2026
10K
Shares to sell
$537.1K
Approx. market value
10K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Previously Exercised Options
Cash
3/5/2026
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/5/2026 | Previously Exercised Options Cash | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
10K
Market value
$537.1K
3/5/2026
Total
Units
10K
Value
$537.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/5/2026 | 10K | $537.1K | NASDAQ | Planned |
| Total | 10K | $537.1K | ||